Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature.

Sabbatino F, Marra A, Liguori L, Scognamiglio G, Fusciello C, Botti G, Ferrone S, Pepe S.

J Immunother Cancer. 2018 Nov 20;6(1):126. doi: 10.1186/s40425-018-0439-2.

2.

Immune Checkpoint Inhibitors in Melanoma and HIV Infection.

Marra A, Scognamiglio G, Peluso I, Botti G, Fusciello C, Filippelli A, Ascierto PA, Pepe S, Sabbatino F.

Open AIDS J. 2017 Nov 14;11:91-100. doi: 10.2174/1874613601711010091. eCollection 2017. Review.

3.

Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.

Marra A, Ferrone CR, Fusciello C, Scognamiglio G, Ferrone S, Pepe S, Perri F, Sabbatino F.

Anticancer Agents Med Chem. 2018;18(2):166-181. doi: 10.2174/1871520618666171219115335.

PMID:
29256359
4.

A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram.

Cong J, Wang Y, Zhang X, Zhang N, Liu L, Soukup K, Michelakos T, Hong T, DeLeo A, Cai L, Sabbatino F, Ferrone S, Lee H, Levina V, Fuchs B, Tanabe K, Lillemoe K, Ferrone C, Wang X.

Cancer Lett. 2017 Nov 28;409:9-19. doi: 10.1016/j.canlet.2017.08.028. Epub 2017 Aug 30.

5.

Epigenetic control of gene expression: Potential implications for cancer treatment.

Perri F, Longo F, Giuliano M, Sabbatino F, Favia G, Ionna F, Addeo R, Della Vittoria Scarpati G, Di Lorenzo G, Pisconti S.

Crit Rev Oncol Hematol. 2017 Mar;111:166-172. doi: 10.1016/j.critrevonc.2017.01.020. Epub 2017 Feb 4. Review.

PMID:
28259291
6.

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

Botti G, Fratangelo F, Cerrone M, Liguori G, Cantile M, Anniciello AM, Scala S, D'Alterio C, Trimarco C, Ianaro A, Cirino G, Caracò C, Colombino M, Palmieri G, Pepe S, Ascierto PA, Sabbatino F, Scognamiglio G.

J Transl Med. 2017 Feb 23;15(1):46. doi: 10.1186/s12967-017-1150-7.

7.

"Idealized" vs. "True" learning curves: the case of laparoscopic liver resection.

Villani V, Bohnen JD, Torabi R, Sabbatino F, Chang DC, Ferrone CR.

HPB (Oxford). 2016 Jun;18(6):504-9. doi: 10.1016/j.hpb.2016.03.610. Epub 2016 Apr 26.

8.

Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.

Villani V, Mahadevan KK, Ligorio M, Fernández-Del Castillo C, Ting DT, Sabbatino F, Zhang I, Vangel M, Ferrone S, Warshaw AL, Lillemoe KD, Wargo J, Deshpande V, Ferrone CR.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):609-617. Epub 2016 Mar 28.

PMID:
27020585
9.

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma.

Sabbatino F, Wang Y, Scognamiglio G, Favoino E, Feldman SA, Villani V, Flaherty KT, Nota S, Giannarelli D, Simeone E, Anniciello AM, Palmieri G, Pepe S, Botti G, Ascierto PA, Ferrone CR, Ferrone S.

J Natl Cancer Inst. 2016 Feb 5;108(7). doi: 10.1093/jnci/djv435. Print 2016 Jul.

10.

HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.

Sottile R, Pangigadde PN, Tan T, Anichini A, Sabbatino F, Trecroci F, Favoino E, Orgiano L, Roberts J, Ferrone S, Kärre K, Colucci F, Carbone E.

Eur J Immunol. 2016 Feb;46(2):409-19. doi: 10.1002/eji.201445289. Epub 2015 Dec 20.

11.

Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells.

Tsao CY, Sabbatino F, Cheung NK, Hsu JC, Villani V, Wang X, Ferrone S.

Oncoimmunology. 2015 Apr 2;4(8):e1023975. eCollection 2015 Aug.

12.

PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma.

Sabbatino F, Villani V, Yearley JH, Deshpande V, Cai L, Konstantinidis IT, Moon C, Nota S, Wang Y, Al-Sukaini A, Zhu AX, Goyal L, Ting DT, Bardeesy N, Hong TS, Fernandez-del Castillo C, Tanabe KK, Lillemoe KD, Ferrone S, Ferrone CR.

Clin Cancer Res. 2016 Jan 15;22(2):470-8. doi: 10.1158/1078-0432.CCR-15-0715. Epub 2015 Sep 15.

13.

Melanoma initiating cells: where do we stand?

Villani V, Sabbatino F, Ferrone CR, Ferrone S.

Melanoma Manag. 2015 May;2(2):109-114. doi: 10.2217/mmt.15.2. Epub 2015 May 18. No abstract available.

14.

Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.

Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesy N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1609. doi: 10.1245/s10434-015-4510-7. No abstract available.

PMID:
25786746
15.

Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.

Ferrone CR, Marchegiani G, Hong TS, Ryan DP, Deshpande V, McDonnell EI, Sabbatino F, Santos DD, Allen JN, Blaszkowsky LS, Clark JW, Faris JE, Goyal L, Kwak EL, Murphy JE, Ting DT, Wo JY, Zhu AX, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

Ann Surg. 2015 Jan;261(1):12-7. doi: 10.1097/SLA.0000000000000867.

16.

Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.

Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1604. doi: 10.1245/s10434-014-4340-z. No abstract available.

17.

The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.

Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V.

Ann Surg Oncol. 2016 Jan;23(1):290-6. doi: 10.1245/s10434-014-4247-8. Epub 2014 Dec 18. Erratum in: Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1604. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1609.

18.

Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors.

Sabbatino F, Wang Y, Wang X, Schwab JH, Ferrone S, Ferrone CR.

Semin Oncol. 2014 Oct;41(5):685-99. doi: 10.1053/j.seminoncol.2014.08.007. Epub 2014 Aug 12. Review.

PMID:
25440613
19.

Genetic evolution of T-cell resistance in the course of melanoma progression.

Sucker A, Zhao F, Real B, Heeke C, Bielefeld N, Maβen S, Horn S, Moll I, Maltaner R, Horn PA, Schilling B, Sabbatino F, Lennerz V, Kloor M, Ferrone S, Schadendorf D, Falk CS, Griewank K, Paschen A.

Clin Cancer Res. 2014 Dec 15;20(24):6593-604. doi: 10.1158/1078-0432.CCR-14-0567. Epub 2014 Oct 7.

20.

Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation.

Sabbatino F, Fusciello C, Somma D, Pacelli R, Poudel R, Pepin D, Leonardi A, Carlomagno C, Della Vittoria Scarpati G, Ferrone S, Pepe S.

Cytometry A. 2014 Nov;85(11):953-61. doi: 10.1002/cyto.a.22563. Epub 2014 Sep 2.

21.

Blocking the formation of radiation-induced breast cancer stem cells.

Wang Y, Li W, Patel SS, Cong J, Zhang N, Sabbatino F, Liu X, Qi Y, Huang P, Lee H, Taghian A, Li JJ, DeLeo AB, Ferrone S, Epperly MW, Ferrone CR, Ly A, Brachtel EF, Wang X.

Oncotarget. 2014 Jun 15;5(11):3743-55.

22.

Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma.

Scognamiglio G, Cantile M, Scala S, Cecere S, Russo F, Collina F, Marra L, Sabbatino F, Botti G, Franco R.

Int J Clin Exp Med. 2014 Apr 15;7(4):1175-9. eCollection 2014. No abstract available.

23.

Tissue Micro Arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma.

Scognamiglio G, Cantile M, Scala S, Cecere S, Russo F, Collina F, Marra L, Sabbatino F, Botti G, Franco R.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1814-8. eCollection 2014. No abstract available.

24.

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.

Sabbatino F, Wang Y, Wang X, Flaherty KT, Yu L, Pepin D, Scognamiglio G, Pepe S, Kirkwood JM, Cooper ZA, Frederick DT, Wargo JA, Ferrone S, Ferrone CR.

Oncotarget. 2014 Apr 15;5(7):1926-41.

25.

Ipilimumab in the treatment of metastatic melanoma: management of adverse events.

Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S.

Onco Targets Ther. 2014 Feb 19;7:203-9. doi: 10.2147/OTT.S57335. eCollection 2014. Review.

26.

Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma.

Wang Y, Sabbatino F, Wang X, Ferrone S.

Methods Mol Biol. 2014;1102:523-35. doi: 10.1007/978-1-62703-727-3_28.

PMID:
24258997
27.

Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96.

Fauci JM, Sabbatino F, Wang Y, Londoño-Joshi AI, Straughn JM Jr, Landen CN, Ferrone S, Buchsbaum DJ.

Gynecol Oncol. 2014 Jan;132(1):203-10. doi: 10.1016/j.ygyno.2013.10.038. Epub 2013 Nov 9.

PMID:
24216048
28.

Emerging BRAF inhibitors for melanoma.

Sabbatino F, Wang Y, Wang X, Ferrone S, Ferrone CR.

Expert Opin Emerg Drugs. 2013 Dec;18(4):431-43. doi: 10.1517/14728214.2013.842975. Epub 2013 Sep 27. Review.

PMID:
24073999
29.

Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy?

Sabbatino F, Ferrone S.

Clin Cancer Res. 2013 Mar 1;19(5):958-60. doi: 10.1158/1078-0432.CCR-12-3586. Epub 2013 Jan 22.

30.

Multidisciplinary approach to patient with malignant melanoma.

Scarpati GD, Fusciello C, Sabbatino F, Ferrone S, Caponigro F, Perri F, Carlomagno C, Pepe S.

Anticancer Agents Med Chem. 2013 Jul 1;13(6):887-900.

PMID:
23272971
31.

Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells.

Sabbatino F, Schwab JH, Ferrone S, Ferrone CR.

Clin Transpl. 2013:453-63. Review.

PMID:
25095541
32.

"Fast track surgery" in the north-west of Italy: influence on the orientation of surgical practice.

Pozzi G, Falcone A, Sabbatino F, Solej M, Nano M.

Updates Surg. 2012 Jun;64(2):131-44. doi: 10.1007/s13304-012-0154-3. Epub 2012 Apr 18.

PMID:
22527810
33.

[Surgical treatment of internal duodenal diverticulum. Report of 2 clinical cases].

Massucco P, Sabbatino F, Fornari M, De Paolis P, Garino M, Fusi D, Vergnano G.

Minerva Chir. 1999 Nov;54(11):813-7. Italian.

PMID:
10638156

Supplemental Content

Loading ...
Support Center